Imaging News

In adults being evaluated for cardiac function by echocardiography, an initial assessment of left ventricular ejection fraction by artificial intelligence was superior to an assessment by a sonographer, researchers reported.

Healio and Cardiology Today have compiled a list of the top news in cardiology of August 2022.

Using noninvasive 18F-sodium fluoride PET and coronary CTA to detect “hot” disease in arteries, researchers were able to predict which patients with recent MI would have recurrent coronary events.

In the AXIOMATIC-SSP trial, milvexian, a novel factor XIa inhibitor, was protective against ischemic stroke with no increased risk for intracranial hemorrhage compared with placebo in patients requiring secondary prevention.

In the DANCAVAS trial, an invitation for comprehensive imaging-based CV screening did not significantly lower the incidence of all-cause death after 5 years among men aged 65 to 74 years, but results suggest a benefit in men younger than 70.

In adults with HF with preserved or mildly reduced ejection fraction, neprilysin inhibition with sacubitril/valsartan did not impair cognitive function compared with valsartan, according to a speaker.

Advances in imaging techniques and new treatments are changing the management of recurrent pericarditis, improving outcomes for patients with formerly treatment-resistant disease, researchers reported.

Motion analysis of video recorded on a smartphone accurately identified carotid artery stenosis in adults, demonstrating utility for a tool that could improve ischemic stroke outcomes.

Dyad Medical announced its application providing data-driven analysis of echocardiogram images has received 510(k) clearance from the FDA.

Sex-specific differences in the performance of noninvasive testing for ischemic heart disease necessitate a sex-based diagnostic workup with a multimodality approach to better understand women’s chest pain symptoms, researchers reported.